Change in Blood Insulin Level – Metabolic Syndrome Clinical Study

• Overview (study design, subjects background, etc.) – metabolic syndrome clinical study

Therapeutic intervention for Group C: standard-of-care
Therapeutic intervention for Group R: standard-of-care and RE therapy

After eight weeks of therapy, fasting plasma insulin and 2-hour postprandial plasma insulin levels in Group R were statistically significantly lower than in Group C.

On the other hand, after eight weeks of therapy, fasting plasma glucose and 2-hour postprandial plasma glucose levels in Group R were statistically significantly lower than in Group C.

Change in Blood Glucose  

From these, adding RE therapy to standard-of-care was inferred to be effective in lowering blood insulin and blood glucose levels simultaneously in patients with metabolic syndrome. The simultaneous decrease in blood insulin and glucose levels implies a reduction in insulin resistance.

---